Systematic review / meta-analysis / 2018
Probiotics did not significantly reduce the occurrence of infections, duration of episodes, mortality, or adverse events in older adults compared to placebo.
A systematic review and meta-analysis of randomized placebo-controlled trials was conducted to evaluate the efficacy and safety of probiotics for infections in older adults. Fifteen articles totaling 5,916 participants (mean age 75.21 years) were analyzed. Probiotics showed no significant difference compared to placebo for infection occurrence (RR 0.90, 95% CI 0.76 to 1.08), adverse events (RR 1.01, 95% CI 0.91 to 1.12), mortality (RR 1.09, 95% CI 0.70 to 1.72), or mean duration of infection episodes (MD -0.35, 95% CI -1.57 to 0.87). The authors concluded that current low-quality evidence does not support using probiotics to reduce infections in older adults.
- Study type
- Systematic review and meta-analysis of randomized placebo-controlled trials
- Who was studied
- 5,916 older adults across 15 articles (mean age 75.21 years)
- What was measured
- Occurrence of infection, quality of life, mortality, mean duration of infection per episode, and adverse events
THE PAPER
Effectiveness of probiotics on the occurrence of infections in older people: systematic review and meta-analysis.
Wachholz PA, Nunes VDS, Polachini do Valle A, Jacinto AF, Villas-Boas PJF. Age Ageing, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.